Tumour suppressor CDKN2A inhibits the cyclin-dependent kinases (Cdk4 and Cdk6) that initiate the phosphorylation of the pRb (Ruas and Peters, 1998; Sherr and Roberts, 1999). The gene discussed is CDK4; the disease is neoplasm.